Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26    source : Jaguarhealth.gcs-web.com    save search
Jaguar Health Announces Publication in Breast Cancer Research and Treatment of Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients
Published: 2022-10-26 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.1486 -9.89% 24M twitter stocktwits trandingview |
Health Technology
 | | O: -0.35% H: 2.85% C: 2.56%
treatment research diarrhea breast health crofelemer cancer publication study
Gainers vs Losers
80% 20%

Top 10 Gainers
TIRX | $1.13 133.09% 44M twitter stocktwits trandingview |

AGBA | $0.8978 124.45% 60M twitter stocktwits trandingview |
Finance
BPTH | $6.18 90.74% 39M twitter stocktwits trandingview |
Health Technology
INVO | $1.44 89.47% 3M twitter stocktwits trandingview |
Health Technology
XPON | $2.66 37.82% 5.2M twitter stocktwits trandingview |

SINT | $0.0504 35.12% 300M twitter stocktwits trandingview |
Health Technology
THCH | $1.38 32.69% 9.9M twitter stocktwits trandingview |
n/a
ALRN | $5.605 31.88% 210K twitter stocktwits trandingview |
Health Technology
HOLO | $2.92 30.36% 22M twitter stocktwits trandingview |

SMSI 4 | $2.53 29.74% 510K twitter stocktwits trandingview |
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.